Global Dermatophytosis Treatment Market: Overview
Keratin is a material that is found in the external layer of the nails, skin, and hair. Dermatophytosis is an infection that is caused by the fungi that feed on the keratin. It is affected by both human beings and animals and they are also referred as dermatophytosis. Symptoms that are seen when suffering from dermatophytosis are itching, dryness of the infected area, scaling, broken hair, rashes, redness, separation of the nail from the nail bed, nail dystrophy, hair loss, and nail discoloration. The people who have weak immune system and those who play sports are at higher risk of dermatophytosis.
Global Dermatophytosis Treatment Market: Segmentation
The global dermatophytosis treatment market is globally segmented into its diagnosis, use of drugs, and regions. On the basis of diagnosis, the global market is segregated into the microscopic test, woods test, culture test, and others. Based on the way the drugs are used, the market is categorized into econazole, miconazole, terbinafine, corticosteroid, itraconazole, imidazole, clotrimazole, ketoconazole, clotrimazole, terbinafine, griseofulvin, and others. The different regions where the dermatophytosis treatment market is diversified include North America, Asia-Pacific, Europe, and Rest of the World.
Global Dermatophytosis Treatment Market: Growth Factors
The major factor that is driving the dermatophytosis market is the increasing number of population that are having weak immunity system. The immune system is weakened as the age increases; the increasing rate of the geriatric population is also one of the factors that contribute to the market growth. The increasing incidences of the diseases that are acquired by the hospitals and the sedentary lifestyle contribute to the market growth. The factors that hamper the market growth are a lack of awareness about the disease and its treatment among the people.
Global Dermatophytosis Treatment Market: Regional Analysis
The global dermatophytosis treatment market is dominated by the North America. The second place is held by Europe. The factors that are favoring these regional markets of dermatophytosis treatment market are the availability of immensely developed healthcare infrastructure, greater healthcare spending, increased awareness about the benefits of early diagnosis and treatment of dermatophytosis, favorable reimbursement coverage, a high rate of awareness regarding dermatophytosis, and availability of advanced healthcare facilities. The market in the Asia Pacific region is also growing and will progress in the future. The key factors that are contributing to the market growth in the Asia-Pacific regions are rising literacy rate, the rise in government support to improve healthcare facilities, improving healthcare infrastructure, and growing healthcare spending. In the emerging countries India and China the dermatophytosis market is growing swiftly owing to the increase in the medical tourism. The other countries such as Argentina, Brazil, and Mexico are also showing huge development in the dermatophytosis market.
Global Dermatophytosis Treatment Market: Competitive Players
The major market players in the dermatophytosis treatment market include Quinnova Pharmaceuticals, Inc., Tinea Pharmaceuticals, AmDerma Pharmaceuticals, LLC, Merz Pharma GmbH & Co. KgaA, Novartis AG, Sun Pharmaceutical Industries Limited, NB Therapeutics, Inc., Valeant Pharmaceuticals International, Inc., and Perrigo Company Plc.
Global Dermatophytosis Treatment Market: Regional Segment Analysis
What Reports Provides